Headline
The latest stories from AHA Today.
The Food and Drug Administration today announced it has revoked the emergency use authorizations for the Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test and Simoa SARS-CoV-2 N Protein Antigen Test.
The Department of Health and Human Services’ Office on Trafficking in Persons last week issued a request for information on forced labor in health care supply chains to inform implementation of the National Strategy for a Resilient Public Health Supply Chain and related efforts on forced labor.
An overview of an AHA-convened panel at Aspen Ideas: Health, part of the Aspen Institute’s Aspen Ideas Festival.
The AHA’s American Society for Health Care Engineering and American Society for Health Care Risk Management has named their new executive director.
HHS approved Colorado's Section 1332 State Innovation Waiver amendment request to create the "Colorado Option.
To increase monkeypox testing capacity during the U.S. outbreak, the CDC began shipping orthopoxvirus tests to five commercial laboratory companies.
The CDC endorsed Moderna’s COVID-19 vaccine for children aged 6-17.
CMS released Frequently Asked Questions regarding No Surprises Act implementation.
Following today’s U.S. Supreme Court decision in Dobbs v. Jackson Women’s Health Organization, a statement from AHA General Counsel.
The House today voted to pass bipartisan legislation to help reduce gun violence in communities.